Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Airway Protection Deficits in Parkinson's Disease
NCT02390089Phase 1Completed
- Sponsor
- University of Florida
- Start
- Apr 2015
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by University of Florida. Primary endpoints: Urge-to-cough sensitivity at 30 minutes and Positive/negative cough response at 10 minutes. Started Apr 2015; status: completed.
Beyond the preview
Go deeper on NCT02390089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02390089.